In vitro dissolution, drug bioavailability, and the spiral of scienceSWARBRICK, J.Pharmaceutical technology. 1997, Vol 21, Num 6, pp 68-72, issn 0147-8087, 3 p.Article

TIME-DEPENDENT SURFACE BEHAVIOR OF DIPALMITOYLLECITHIN AND LUNG ALVEOLAR SURFACTANT MONOLAYERSMUNDEN JW; SWARBRICK J.1973; BIOCHIM. BIOPHYS ACTA; PAYS-BAS; DA. 1973; VOL. 291; NO 2; PP. 344-350; BIBL. 15 REF.Serial Issue

INTERACTION OF CHOLESTEROL WITH DIBENZANTHRACENES AT AIR-WATER INTERFACE = L'INTERACTION DU CHOLESTEROL AVEC LES DIBENZANTHRACENES A L'INTERFACE AIR-EAUBELMONTE AA; SWARBRICK J.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 3; PP. 481-483; BIBL. 14 REF.Serial Issue

CORRELATIONS BETWEEN IN VITRO TRANSPORT IN A THREE-PHASE MODEL CELL AND IN VIVO ABSORPTION OF A SERIES OF SULFANILAMIDES = CORRELATIONS ENTRE LE TRANSPORT IN VITRO DANS UNE CELLULE MODELE A 3PHASES ET L'ABSORPTION IN VIVO D'UNE SERIE DE SULFANILAMIDESAUGUSTINE MA; SWARBRICK J.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1656-1658; BIBL. 12REF.Serial Issue

Advances in controlled drug deliverySWARBRICK, J.STP pharma pratiques. 1996, Vol 6, Num 1, pp 53-60, issn 1157-1497, 7 p.Article

IN VITRO DISSOLUTION OF DAPSONESWARBRICK J; MA D.1981; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1981; VOL. 33; NO 12; PP. 787-789; BIBL. 14 REF.Article

THE DISTRIBUTION OF NON-ELECTROLYTES BETWEEN HUMAN STRATUM CORNEUM AND WATER.ROBERTS MS; ANDERSON RA; MOORE DE et al.1977; AUSTRAL. J. PHARM. SCI.; AUSTRAL.; DA. 1977; VOL. 6; NO 3; PP. 77-82; BIBL. 1/2 P.Article

MICELLAR SOLUBILIZATION OF ORANGE OT BY A SERIES OF N-ALKYL BETAINESSWARBRICK J; GALOWNIA J; BATES TR et al.1972; J. COLLOID INTERFACE SCI.; U.S.A.; DA. 1972; VOL. 41; NO 3; PP. 609-611; BIBL. 9 REF.Serial Issue

INTERACTION OF MONOMOLECULAR FILMS OF BIOLOGICAL SIGNIFICANCE WITH HEAVY METALS IONS AND COMPLEXES AT THE AIR-WATER INTERFACEGORDZIEL SA; FLANAGAN DR; SWARBRICK J et al.1982; J. COLLOID INTERFACE SCI.; ISSN 0021-9797; USA; DA. 1982; VOL. 86; NO 1; PP. 178-184; BIBL. 24 REF.Article

PERMEABILITY OF HUMAN EPIDERMIS TO PHENOLIC COMPOUNDS.ROBERTS MS; ANDERSON RA; SWARBRICK J et al.1977; J. PHARM. PHARMACOL.; G.B.; DA. 1977; VOL. 29; NO 11; PP. 677-683; BIBL. 23 REF.Article

FACTORS AFFECTING WATER VAPOR TRANSMISSION THROUGH POLYMER FILMS APPLIED TO SOLID SURFACESAMANN AH; LINDSTROM RE; SWARBRICK J et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 6; PP. 931-933; BIBL. 2 REF.Article

DRUG PERMEATION THROUGH HUMAN SKIN. I: EFFECT OF STORAGE CONDITIONS OF SKINSWARBRICK J; LEE G; BROM J et al.1982; J. INVEST. DERMATOL.; ISSN 0022-202X; USA; DA. 1982; VOL. 78; NO 1; PP. 63-66; BIBL. 19 REF.Article

IN VITRO DISSOLUTION AND IN VIVO ABSORPTION OF NITROFURANTOIN FROM DEOXYCHOLIC ACID COPRECIPITATESSTOLL RG; BATES TR; SWARBRICK J et al.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 1; PP. 65-68; BIBL. 14REF.Serial Issue

FACTORS AFFECTING VAPOR TRANSMISSION THROUGH FREE POLYMER FILMSSWARBRICK J; AMANN AH; LINDSTROM RE et al.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1645-1647; BIBL. 5REF.Serial Issue

THE PERCUTANEOUS ABSORPTION OF PHENOLIC COMPOUNDS: THE MECHANISM OF DIFFUSION ACROSS THE STRATUM CORNEUMROBERTS MS; ANDERSON RA; SWARBRICK J et al.1978; J. PHARM. PHARMACOL.; GBR; DA. 1978; VOL. 30; NO 8; PP. 486-490; BIBL. 19 REF.Article

The influence of liquid crystalline phases on drug percutaneous absorption. II: Permeation studies through excised human skinSWARBRICK, J; SIVERLY, J. R.Pharmaceutical research. 1992, Vol 9, Num 12, pp 1550-1555, issn 0724-8741Article

AMIDE-WATER INTERACTIONS IN COSOLVENT SYSTEMS. I. SOLUBILITIES AND APPARENT MOLAR VOLUMES OF METHYL PARABEN.GIAQUINTO AR; LINDSTROM RE; SWARBRICK J et al.1977; J. SOLUT. CHEM.; G.B.; DA. 1977; VOL. 6; NO 10; PP. 687-701; BIBL. 25 REF.Article

BIOLOGICAL IMPLICATIONS OF CADMIUM-PHOSPHOLIPID MONOLAYERSBELMONTE AA; SWARBRICK J; JENSEN RG et al.1972; LIPIDS; U.S.A.; DA. 1972; VOL. 7; NO 7; PP. 490-492; BIBL. 8REF.Serial Issue

The influence of liquid crystalline phases on drug percutaneous absorption. I: Development of a vehicleSWARBRICK, J; SIVERLY, J. R.Pharmaceutical research. 1992, Vol 9, Num 12, pp 1546-1549, issn 0724-8741Article

Sustained-release delivery systems. I: Phase diagram studies of dapsone and selected derivativesTSONG-TOH YANG; SWARBRICK, J.Journal of pharmaceutical sciences. 1986, Vol 75, Num 1, pp 53-56, issn 0022-3549Article

The prolonged retention of sodium cromoglycate in the rabbit eyeSWARBRICK, J; SHREWSBURY, R. P.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 2, pp 121-122, issn 0022-3573Article

Effects of ionization on the percutaneous absorption of drugs: partitioning of nicotine into organic liquids and hydrated stratum corneumOAKLEY, D. M; SWARBRICK, J.Journal of pharmaceutical sciences. 1987, Vol 76, Num 12, pp 866-871, issn 0022-3549Article

DISPOSITION OF TOPICALLY APPLIED SODIUM CROMOGLYCATE IN THE ALBINO RABBIT EYELEE VHL; SWARBRICK J; STRATFORD RE JR et al.1983; JOURNAL OF PHARMACY AND PHARMACOLOGY; ISSN 0022-3573; GBR; DA. 1983; VOL. 35; NO 7; PP. 445-450; BIBL. 1 P.Article

Sustained-release delivery systems. II: In vitro dissolution of 4,4'-sulfonylbisbenzamine (dapsone)―N-dodecanoyl-4,4'-sulfonylbisbenzamine comeltsTSONG-TOH YANG; SWARBRICK, J.Journal of pharmaceutical sciences. 1986, Vol 75, Num 3, pp 264-270, issn 0022-3549Article

Sustained release delivery systems. III: Preparation and in vitro dissolution of surface-reacted dapsone particlesSWARBRICK, J; SOMPOL PRAKONGPAN; SUZUKI, K et al.International journal of pharmaceutics. 1986, Vol 32, Num 1, pp 21-29, issn 0378-5173Article